Research On Internal Control Optimization Of KeZhiBo Pharmaceutical Company

The pharmaceutical industry belongs to the important field of the government providing health services to the public.The safety of pharmaceutical products is no small matter.The products of pharmaceutical enterprises are directly related to the well-being of the people.The medical safety is related to the safety of the people.However,China has been successively occurring since 2018.Drug production safety accidents,from the Changchun longevity vaccine to the Jiangsu Jinhu expired vaccine incident,a series of serious problem vaccine incidents caused great public concern and panic,temporarily ignore the moral level,only analyze the vaccine event from the perspective of company management The reason for the frequent occurrence is obvious that there are major defects in the internal control of enterprises with safety production accidents.Along with the convening of the National People's Congress in 2019,the words "vaccine safety" appeared frequently in the speeches of the representatives of the "two sessions" of the country,which once again provoked the sensitivity of the general public to the health and safety of medicines,and how to eliminate the safety of domestic people against domestic vaccines.Questioning sexuality,how to save the crisis of trust in China's drug safety issues has become an urgent issue for the Chinese government and the entire pharmaceutical industry.Establishing a sound and effective internal control system is conducive to enterprises to improve the company's risk management capabilities by using modern and scientific management methods,integrating various resources within the company,and thus improving the management level of the company.A sound internal control system can reduce the operating costs of enterprises,strengthen the company's profitability and sustainable development capabilities,and help achieve the company's stra-tegic goals.Therefore,based on the COSO internal control framework,this paper selects Kezhibo Pharmaceutical Co.,Ltd.with more than 50 development history as a case,and combines the company's actual operation and management methods,using case analysis method and literature research method to deepen the status of internal control of the company.Research,a more comprehensive analysis of corporate risks,found that there are many problems in the management of Kezhibo Pharmaceutical Co.,Ltd.,combined with the actual management links such as production and sales of Ke Zhibo,to find out the root cause of internal control problems.Perfecting the internal control system of Kezhibo Pharmaceutical Co.,Ltd.laid a solid foundation.The integration of internal control measures and management system is conducive to balancing the relationship between internal control and work efficiency,effectively improving the market competitiveness of enterprises,improving the ability of sustainable development and resource integration,and aiming at the management status of Kezhibo Pharmaceutical Co.,Ltd.The existing internal control system,proposed clear and specific solutions and suggestions,is conducive to Kezhibo Pharmaceutical Company to become a domestic first-class pharmaceutical company.